EFFICACY AND SAFETY OF APIXABAN COMPARED TO WARFARIN FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN 18,201 PATIENTS WITH ATRIAL FIBRILLATION: PRIMARY RESULTS OF THE ARISTOTLE TRIAL

被引：2
|
作者：
Ezekowitz, J.
Dorian, P.
Granger, C.
Alexander, J.
Lopes, R.
Hanna, M.
Geraldes, M.
Wallentin, L.
机构：
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2011年 / 27卷 / 05期
关键词：
D O I：
10.1016/j.cjca.2011.07.611
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S334 / S334
页数：1
相关论文
共 50 条
  • [31] Apixaban Compared With Warfarin for Stroke Prevention in Atrial Fibrillation Implications of Time in Therapeutic Range
    Gallego, Pilar
    Antonio Vilchez, Juan
    Lane, Deirdre A.
    CIRCULATION, 2013, 127 (22) : 2163 - 2165
  • [32] Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Garcia, David A.
    Fisher, Deborah A.
    Mulder, Hillary
    Wruck, Lisa
    De Caterina, Raffele
    Halvorsen, Sigrun
    Granger, Christopher B.
    Held, Claes
    Wallentin, Lars
    Alexander, John H.
    Lopes, Renato D.
    AMERICAN HEART JOURNAL, 2020, 221 : 1 - 8
  • [33] BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL
    Sandhu, Roopinder K.
    Ezekowitz, Justin
    Andersson, Ulrika
    Alexander, John
    Granger, Christopher
    Halvorsen, Sigrun
    Hanna, Michael
    Hijazi, Ziad
    Jansky, Petr
    Lopes, Renato
    Wallentin, Lars
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A284 - A284
  • [34] Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial
    Lopes, Renato D.
    Al-Khatib, Sana M.
    Wallentin, Lars
    Yang, Hongqiu
    Ansell, Jack
    Cecilia Bahit, M.
    De Caterina, Raffaele
    Dorian, Paul
    Easton, J. Donald
    Erol, Cetin
    Ezekowitz, Justin A.
    Gersh, Bernard J.
    Granger, Christopher B.
    Hohnloser, Stefan H.
    Horowitz, John
    Hylek, Elaine M.
    McMurray, John J. V.
    Mohan, Puneet
    Vinereanu, Dragos
    Alexander, John H.
    LANCET, 2012, 380 (9855): : 1749 - 1758
  • [35] History of Bleeding and Outcomes with Apixaban versus Warfarin in Patients with Atrial Fibrillation in the ARISTOTLE Trial
    De Caterina, Raffaele
    Andersson, Ulrika
    Alexander, John H.
    Bahit, M. Cecilia
    Commerford, Patrick J.
    Goto, Shinya
    Granger, Christopher B.
    Hanna, Michael
    Held, Claes
    Hohnloser, Stefan H.
    Hylek, Elaine M.
    Lanas, Fernando
    Lopes, Renato D.
    Lopez-Sendon, Jose L.
    Wallentin, Lars
    CIRCULATION, 2014, 130
  • [36] Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
    Garcia, David A.
    Wallentin, Lars
    Lopes, Renato D.
    Thomas, Laine
    Alexander, John H.
    Hylek, Elaine M.
    Ansell, Jack
    Hanna, Michael
    Lanas, Fernando
    Flaker, Greg
    Commerford, Patrick
    Xavier, Denis
    Vinereanu, Dragos
    Yang, Hongqiu
    Granger, Christopher B.
    AMERICAN HEART JOURNAL, 2013, 166 (03) : 549 - 558
  • [37] Comparison of the Efficacy and Safety of Apixaban and Warfarin in the Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation: A Meta-Analysis
    Memon, Rahat A.
    Hamdani, Syed Shah Qasim
    Usama, Ali
    Aisha, F. N. U.
    Kundi, Hayan
    Mathavan, Mohit
    Khalid, Malaika
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [38] Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Avezum, Alvaro
    Lopes, Renato D.
    Schulte, Phillip J.
    Lanas, Fernando
    Gersh, Bernard J.
    Hanna, Michael
    Pais, Prem
    Erol, Cetin
    Diaz, Rafael
    Cecilia Bahit, M.
    Bartunek, Jozef
    De Caterina, Raffaele
    Goto, Shinya
    Ruzyllo, Witold
    Zhu, Jun
    Granger, Christopher B.
    Alexander, John H.
    CIRCULATION, 2015, 132 (08) : 624 - 632
  • [39] Apixaban versus Warfarin for Stroke Prevention in Patients With End Stage Renal Disease on Hemodialysis and Atrial Fibrillation: Results of a Randomized Clinical Trial Assessing Safety
    Pokorney, Sean D.
    Chertow, Glenn M.
    Al-Khalidi, Hussein
    Gallup, Dianne
    Dignacco, Pat
    Mussina, Kurt
    Bansal, Nisha
    Gadegbeku, Crystal A.
    Garcia, David
    Jones-Burton, Charlotte
    Lopes, Renato D., Sr.
    Mahaffey, Kenneth W.
    Middleton, John
    Mills, Donna
    Rymer, Jennifer A.
    Thadhani, Ravi
    Thomas, Kevin L.
    Winkelmayer, Wolfgang C.
    Granger, Christopher B.
    CIRCULATION, 2019, 140 (25) : E988 - E989
  • [40] Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
    Fox, Keith A. A.
    Piccini, Jonathan P.
    Wojdyla, Daniel
    Becker, Richard C.
    Halperin, Jonathan L.
    Nessel, Christopher C.
    Paolini, John F.
    Hankey, Graeme J.
    Mahaffey, Kenneth W.
    Patel, Manesh R.
    Singer, Daniel E.
    Califf, Robert M.
    EUROPEAN HEART JOURNAL, 2011, 32 (19) : 2387 - 2394
12345